Showing results (561-570 of 578) with videos related to

Sort By:
Pageof 58
The Journal of Thoracic and Cardiovascular Surgery|October 12, 2024
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapySonali Mitra, Hee-Jin Jang, Allen Kuncheria, et al.
JCI Insight|April 6, 2018
Comprehensive immunoproteogenomic analyses of malignant pleural mesotheliomaHyun-Sung Lee, Hee-Jin Jang, Jong Min Choi, et al.
The Annals of Thoracic Surgery|April 22, 2026
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural MesotheliomaJeffrey B Velotta, Anja C Roden, Jonathan Rice, et al.
Cancer Research|June 16, 2022
Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune MicroenvironmentHee-Jin Jang, Hyun-Sung Lee, Wendong Yu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 29, 2025
Accounting for human-nature linkages in area-based conservation monitoring through social-ecological indicator bundlesNatalie C Ban, Mark H Carr, Emily M Rubidge, et al.
Cancer Immunology Research|April 15, 2018
IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 CancerRan You, Francesco J DeMayo, Jian Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2026
Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancerAtsushi Ito, Sung Wook Kang, Hee-Jin Jang, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancerAtsushi Ito, Sung Wook Kang, Hee-Jin Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural MesotheliomaHee-Jin Jang, Meera Patel, Daniel Y Wang, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
Pageof 58